What is Charles River Laboratories's revenue?

Charles River Laboratories (CRL) generated $4.0B in revenue over the trailing twelve months, up 0.1% year over year.

Is Charles River Laboratories profitable?

Charles River Laboratories is not currently profitable: it reported a net loss of $184.7M over the trailing twelve months, a -4.6% net margin.

What are Charles River Laboratories's profit margins?

Gross margin is 84.7% and operating margin is 13.0%, with a -4.6% net margin.

What is Charles River Laboratories's earnings per share?

Charles River Laboratories's diluted EPS over the trailing twelve months is $-3.70.

Where does Charles River Laboratories's income statement data come from?

Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Charles River Laboratories CRL Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23	FY'22
Total revenue	$4.02B-0.9%	$4.05B-1.9%	$4.13B+3.9%	$3.98B+12.3%
Subscription revenue	$49M-29.0%	$69M-25.9%	$93.1M—	——
Selling, general and administrative	$743.07M-1.1%	$751M+0.4%	$747.86M+12.4%	$665.1M+7.3%
Compensation and benefits	$71.08M+1.7%	$69.89M-3.0%	$72.05M—	——
Depreciation and amortization	$403.31M+11.5%	$361.74M+15.2%	$314.12M+3.4%	$303.87M+14.4%
Provision for credit losses	$6.06M-59.0%	$14.77M-18.9%	$18.23M—	——
Restructuring charges	$99.81M-6.7%	$106.99M+260%	$29.68M—	——
Goodwill impairment	$165M-23.3%	$215M—	$0—	$0—
Impairment charges	$259.08M+400%	$51.83M+23.6%	$41.92M—	——
Operating income	——	——	$617.26M-5.2%	$650.98M+10.4%
Interest expense	$107.03M-15.3%	$126.29M-7.6%	$136.71M+131%	$59.29M-19.8%
Interest income	$4.94M-42.4%	$8.58M+65.0%	$5.2M+566%	$780K+19.6%
Other income (expense), net	——	-$16.52M-117%	$95.54M+213%	$30.52M+180%
Gain (loss) on disposal of assets	——	——	-$995K—	——
Income tax expense	——	$70.87M-29.8%	$100.91M-22.6%	$130.38M+59.2%
Net income	-$144.34M—	——	$474.62M-2.4%	$486.23M+24.4%
Net margin	-3.6%—	——	11.5%-0.7pp	12.2%+1.2pp
Net income attributable to noncontrolling interests	$2.18M-29.6%	$3.09M-46.3%	$5.75M—	——
Diluted earnings per share	-$2.90—	——	$9.23-2.5%	$9.47+24.6%
Basic earnings per share	-$2.90—	——	$9.26-3.3%	$9.58+23.3%
Weighted-average shares, diluted	199.2M-3.7%	206.9M+0.5%	206M+0.4%	205.2M-0.1%
Weighted-average shares, basic	198.6M-3.5%	205.8M+0.5%	204.8M+0.8%	203.1M+1.1%
Accounts Receivable, Credit Loss Expense, Gross	$6.06M-59.0%	$14.77M-18.9%	$18.23M—	——
Net provision (recovery) expense	——	$12.9M—	——	——
Share-Based Payment Arrangement, Decrease for Tax Withholding Obligation	$10.1M-45.4%	$18.5M—	——	——
Share-based compensation expense related to employee stock plans	$71.08M+1.7%	$69.89M-3.0%	$72.05M—	——
Accounts Receivable, Allowance for Credit Loss, Writeoff	$13.9M-37.4%	$22.2M—	——	——
Amortization of capitalized software and acquired intangible assets	$179.07M+29.3%	$138.47M+0.8%	$137.44M-6.2%	$146.58M+17.4%
Amortization of inventory step up	——	——	——	——
Defined Benefit Plan, Amount Recognized in Net Periodic Benefit Cost (Credit) and Other Comprehensive (Income) Loss, before Tax	$7.57M-2.7%	$7.78M+38.3%	$5.63M—	——
Stock options excluded as their inclusion would be anti-dilutive (in shares)	4.1M+85.4%	2.2M-0.4%	2.2M—	——
Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation	$10.43M—	——	$43.27M—	——
Comprehensive Income (Loss), Net of Tax, Attributable to Parent	——	-$98.72M-118%	$540.25M—	——
Less: comprehensive income attributable to noncontrolling interest	$3.34M+1,307%	$237K-94.8%	$4.55M—	——
Comprehensive Income (Loss), Net of Tax, Including Portion Attributable to Noncontrolling Interest	——	-$98.48M-118%	$544.8M—	——
Percentage of unbilled revenue billed during period	——	——	——	——
Percentage of contract liabilities recognized as revenue during period	——	——	——	——
Federal	$10.87M-70.1%	$36.35M-26.0%	$49.09M—	——
Foreign	$97.43M+12.6%	$86.49M+1.3%	$85.36M—	——
Current State And Local Tax Expense Benefit	$9.73M-20.1%	$12.18M-31.7%	$17.82M—	——
Deferred Compensation Arrangement With Individual Compensation Expense	$3.4M+13.3%	$3M+7.1%	$2.8M—	——
Federal	-$40.76M+19.4%	-$50.56M-17.6%	-$42.99M—	——
Deferred Foreign Income Tax Expense Benefit	-$22.42M-224%	-$6.92M-989%	$779K—	——
Deferred taxes	-$75.37M-12.2%	-$67.19M-30.9%	-$51.35M—	——
Deferred and other income taxes	——	-$67.43M-32.5%	-$50.9M-41.9%	-$35.88M-49.5%
State	-$12.2M-25.5%	-$9.72M-6.3%	-$9.14M—	——
Additions (reductions) charged to income tax provision, net	$13.11M+1,258%	$965K+0.2%	$963K—	——
Currency translation and other	$36.39M+320%	-$16.57M-294%	$8.53M—	——
Enacted tax law changes	-$12.94M—	$0—	$0—	——
Deferred Tax Asset, Valuation Allowance, Reductions For Disposals, Restructuring	$0-100%	$1.88M—	$0—	——
Defined Benefit Plan Actual Return On Plan Assets	$4.84M+131%	-$15.71M—	——	——
Defined Benefit Plan Actuarial Gain Loss	$8.31M-22.1%	$10.67M—	——	——
Defined Benefit Plan, Actuarial Gain (Loss), Change in Mortality Assumptions	——	——	-$3.5M—	——
Defined Benefit Plan Assumptions Used Calculating Net Periodic Benefit Cost Discount Rate	——	——	——	——
Expected long-term rate of return on plan assets	$0.04+25.7%	$0.04-10.3%	$0.04—	——
Rate of compensation increase (average)	——	——	——	——
Defined Benefit Plan Benefit Obligation Benefits Paid	$7.23M-10.1%	$8.03M—	——	——
Contributions to benefit plan	$1.99M-63.8%	$5.5M—	——	——
Defined Benefit Plan Curtailments	$0-100%	$7K—	——	——
Defined Benefit Plan Foreign Currency Exchange Rate Changes Benefit Obligation	-$13.5M-502%	$3.36M—	——	——
Defined Benefit Plan Other Changes	-$29K—	$0—	——	——
Defined Benefit Plan Plan Assets Benefits Paid	$7.23M-10.1%	$8.03M—	——	——
Foreign Currency Translation	$13.9M+618%	-$2.69M—	——	——
Other	$14K—	$0—	——	——
Defined Benefit Plan Settlements Benefit Obligation	$0-100%	$74K—	——	——
Defined Benefit Plan Settlements Plan Assets	$0-100%	$74K—	——	——
Defined Contribution Plan Cost Recognized	$26.9M-12.9%	$30.9M-2.2%	$31.6M—	——
Defined Contribution Plan Employers Matching Contribution Annual Vesting Percentage	——	——	——	——
Maximum percentage of annual compensation contributed by the participant (percent)	——	——	——	——
Depreciation	$177.6M-6.6%	$190.2M+7.6%	$176.7M—	——
Effect of exchange rate changes on cash, cash equivalents and restricted cash	——	——	$8.21M—	——
Effective tax rates	$0.17-86.0%	$1.19—	——	——
Income taxes at U.S. statutory rate of 21%	——	——	——	——
Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent	——	——	——	——
Effective Income Tax Rate Reconciliation Change In Enacted Tax Rate	——	——	——	——
Effective Income Tax Rate Reconciliation, Cross-Border, Other, Amount	$17K—	——	——	——
Other	——	——	——	——
Effective Income Tax Rate Reconciliation, FDII, Percent	——	——	——	——
Foreign operations	——	——	——	——
Foreign local tax	——	——	——	——
Global Intangible Low-taxed Income, net of credits	$6.28M—	——	——	——
Global Intangible Low-taxed Income, net of credits	——	——	——	——
Impact of acquisition and restructuring	——	——	——	——
Other	-$0.04—	——	——	——
Nondeductible compensation	——	——	——	——
Effective Income Tax Rate Reconciliation Nondeductible Expense Impairment Losses	——	——	——	——
Nondeductible compensation	$4.96M—	——	——	——
Share-based compensation	——	——	——	——
Excess tax benefits associated with employee equity plans (in percent)	——	——	——	——
State income taxes – net of federal income tax benefit	——	——	——	——
Changes in unrecognized tax benefits	——	——	——	——
Effective Income Tax Rate Reconciliation, Tax Credits and Deductions	——	——	——	——
Tax on unremitted earnings	——	——	——	——
Employee Service Share Based Compensation Allocation Of Recognized Period Costs Capitalized Amount	$0—	$0—	$0—	——
Gain on sale of business and assets	——	——	-$995K-101%	$123.41M+393%
Gain Loss On Sale Of Property Plant Equipment	——	——	——	——
Goodwill Additions	——	——	——	——
Foreign Currency Translation and Other Adjustments	——	-$51.11M—	——	——
Goodwill impairment losses	$165M-23.3%	$215M—	$0—	$0—
Goodwill, Written off Related to Sale of Business Unit	——	——	——	——
Impairment Of Long Lived Assets Held For Use	$259.08M+400%	$51.83M+23.6%	$41.92M—	——
Income Loss From Continuing Operations Before Income Taxes Domestic	-$290.65M-0.1%	-$290.31M-256%	$185.67M—	——
Income Loss From Continuing Operations Before Income Taxes Foreign	$191.14M-50.1%	$383.42M-3.1%	$395.62M—	——
Income (Loss), Including Portion Attributable to Noncontrolling Interest, before Tax	-$99.5M—	——	$581.28M—	——
Federal taxes	$42.29M—	——	——	——
Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount	-$20.9M—	——	——	——
Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount	$3.89M—	——	——	——
Share-based compensation	$4.47M—	——	——	——
Income Taxes Paid, Net	$119.64M-5.1%	$126.1M+39.5%	$90.4M+19.1%	$75.91M+0.6%
Accounts payable	——	——	——	——
Increase (Decrease) in Accounts Receivable	-$35.74M-65.4%	-$21.61M—	——	——
Customer contract deposits	——	——	——	——
Increase (decrease) in contract liabilities and current deferred income	-$38.14M—	——	-$21.74M-138%	$57.66M+530%
Accrued compensation and employee benefits	$81.87M—	——	——	——
Increase (Decrease) in Inventories	——	-$16.8M-127%	$62.3M-20.7%	$78.52M—
Increase (Decrease) in Other Operating Assets and Liabilities, Net	——	——	-$38.64M—	——
Increase in unrecognized tax benefits that would impact effective tax rate	——	——	——	——
Add - Incremental shares under stock-based compensation plans (in shares)	$370K—	——	——	——
Deductible amount under insurance policies	$2M—	——	——	——
Interest Paid, Excluding Capitalized Interest, Operating Activity	$101.72M-17.6%	$123.45M-6.5%	$132.1M+31.1%	$100.75M+42.4%
Inventory, step-up amortization	$24.5M-11.6%	$27.7M—	$0—	——
Inventory Write Down	$12.81M-66.7%	$38.47M+512%	$6.29M—	——
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	-$536.73M+2.6%	-$550.93M—	——	-$42.4M—
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$209.32M+14.6%	-$245.09M+56.5%	-$563.16M+13.7%	-$652.31M+54.9%
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	$737.65M+0.4%	$734.58M+7.4%	$683.9M+10.4%	$619.64M-18.6%
Net Income Loss Attributable To Noncontrolling Interest	$2.18M-29.6%	$3.09M-46.3%	$5.75M—	——
Net income (loss)	-$142.53M—	——	$476.88M—	——
Dividends declared to noncontrolling interests	$6.4M-41.9%	$11.01M—	——	——
Number of reportable segments	——	——	——	——
Other Comprehensive Income Foreign Currency Transaction And Translation Gain Loss Before Reclassification And Tax	$171.5M+232%	-$130.11M-284%	$70.65M—	——
Amortization of prior service costs/(credits)	——	$1.6M+117%	$736K—	——
Other Comprehensive Income (Loss), Before Income Taxes	$178.31M+226%	-$141.67M-307%	$68.5M—	——
Other Comprehensive Income Loss Before Reclassifications Before Tax	——	——	——	——
Other Comprehensive Income Loss Before Tax	——	——	——	——
Other comprehensive income (loss), net of tax	$145.56M+220%	-$120.92M-284%	$65.63M—	——
Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Before Reclassification Adjustments And Tax	-$5.63M-146%	$12.19M+127%	$5.38M—	——
Tax expense (benefit)	$31.59M+276%	-$17.9M-540%	$4.07M—	——
Other Noncash Income (Expense)	——	-$33.25M—	——	——
Other income, net (Note 6)	——	-$16.52M-117%	$95.54M+213%	$30.52M+180%
Other Restructuring Costs	$70.8M+34.1%	$52.8M+192%	$18.07M—	——
Payments For Additional Equity Interests	——	——	——	——
Payment for (Proceeds from) Other Investing Activity	-$3.36M+26.0%	-$4.55M-298%	$2.29M-75.5%	$9.35M—
Payments for Repurchase of Common Stock	$360.67M+203%	$119.18M+393%	$24.16M-37.5%	$38.65M-5.1%
Payments for Restructuring	$58.47M+34.9%	$43.34M+349%	$9.64M—	——
Payments to Acquire Businesses, Net of Cash Acquired	$0—	——	——	——
Payments to Acquire Investments	$20.08M-62.0%	$52.88M-2.5%	$54.22M-65.7%	$158.27M+247%
Payments to Acquire Productive Assets	$219.15M-5.9%	$232.97M-26.9%	$318.53M-1.9%	$324.73M+41.9%
Debt issued (Note 13)	$1.23B+13.5%	$1.08B+39.3%	$776.35M-73.7%	$2.95B-57.5%
Financing — other	-$14.02M+55.4%	-$31.44M-659%	-$4.15M—	——
Proceeds from maturities of marketable securities	$9.1M-78.2%	$41.69M+525%	$6.67M—	——
Proceeds from sales of operations and affiliates	——	$0—	$0—	——
Cash received from option exercises	$714K-97.0%	$23.88M-6.7%	$25.6M+1.9%	$25.11M-45.0%
Certain property insurance, deductibles	$15M—	——	——	——
Retired property, plant and equipment	——	——	——	——
Net additions (releases) charged to costs and expenses	$6.06M-59.0%	$14.77M-18.9%	$18.23M+200%	$6.08M+267%
Redeemable Noncontrolling Interest, Decrease from Redemptions or Purchase of Remaining Equity Interest	——	——	-$1.15M—	——
Redeemable Noncontrolling Interest, Gain (Loss) On Redemptions Or Purchase Of Interests	——	——	$1.15M—	——
Acquisition of redeemable noncontrolling interest	——	——	$45.37M—	——
Repayment of Long-Term Debt, Long-Term Lease Obligation, and Capital Security	$1.35B-9.7%	$1.49B+75.4%	$851.68M-71.0%	$2.93B-53.0%
Representation and warranty insurance, maximum deductible	$4.4M—	——	——	——
Restructuring Reserve Accrual Adjustment1	——	——	——	——
Restructuring Reserve Translation Adjustment	——	-$273K-2,582%	$11K—	——
Revenue From Contract With Customer Excluding Assessed Tax	$4.02B-0.9%	$4.05B-1.9%	$4.13B+3.9%	$3.98B+12.3%
Right Of Use Asset Obtained In Exchange For Finance Lease Liability	$40K—	——	$0-100%	$8.18M+519%
Sales-type lease selling price	$49M-29.0%	$69M-25.9%	$93.1M—	——
Stock-based compensation	$71.08M+1.7%	$69.89M-3.0%	$72.05M-2.1%	$73.62M+3.0%
Expected volatility	——	——	——	——
Weighted-average grant date fair value of stock options (in dollars per share)	——	——	——	——
Granted (in shares)	——	——	——	——
Forfeited or expired (in shares)	——	——	——	——
Risk-free rate	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Expirations in Period	——	——	——	——
Weighted-average dividend yield	——	——	——	——
Granted (in shares)	——	——	——	——
Exercised (in shares)	——	——	——	——
Share Repurchase Program, Excise Tax	——	——	——	——
Tax withholding obligation, shares withheld (in shares)	——	——	——	——
Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercises in Period	——	——	——	——
Shares Issued, Value, Share-Based Payment Arrangement, after Forfeiture	$747K-96.9%	$23.88M-6.7%	$25.6M—	——
Temporary Equity Accretion To Redemption Value	$6.4M-41.9%	$11.01M—	——	——
Adjustment of redeemable noncontrolling interests to redemption value	——	——	-$5.69M—	——
Temporary Equity, Dividends to Redeemable Noncontrolling Interest	——	$12.58M—	——	——
Net income (loss)	——	$1.1M-68.6%	$3.49M—	——
Other comprehensive income (loss), net of tax	$1.27M—	——	——	——
Treasury Stock, Retired, Cost Method, Amount	$0—	$0—	$0—	——
Treasury stock, value, acquired	$360.11M+202%	$119.18M+393%	$24.16M—	——
Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions	$1.35M+68.8%	$801K-80.3%	$4.06M—	——
Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions	$2.34M-11.6%	$2.65M-14.4%	$3.09M—	——
Additions for tax positions of prior years	$3.89M+356%	$852K+18.2%	$721K—	——
Increase (decrease) in amount of unrecognized tax benefits	——	——	——	——
Unrecognized Tax Benefits Reductions Resulting From Lapse Of Applicable Statute Of Limitations	$3.4M+839%	$362K+22.3%	$296K—	——
Venture Capital And Equity Method Investments, Gain (Loss) And Impairments, Net	——	——	$97.83M—	——
EBIT	$307.5M-31.1%	$446.55M-27.7%	$617.26M-5.2%	$650.98M+10.4%
EBITDA	$710.81M-12.1%	$808.29M-13.2%	$931.39M-2.5%	$954.85M+11.6%
EBITDA	$710.81M-12.1%	$808.29M-13.2%	$931.39M-2.5%	$954.85M+11.6%
EBITDA margin	17.7%-2.3pp	20%-2.6pp	22.6%-1.5pp	24%-0.1pp
EBIT	$307.5M-31.1%	$446.55M-27.7%	$617.26M-5.2%	$650.98M+10.4%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Charles River Laboratories.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Charles River Laboratories's revenue?: Charles River Laboratories (CRL) generated $4.0B in revenue over the trailing twelve months, up 0.1% year over year.
Is Charles River Laboratories profitable?: Charles River Laboratories is not currently profitable: it reported a net loss of $184.7M over the trailing twelve months, a -4.6% net margin.
What are Charles River Laboratories's profit margins?: Gross margin is 84.7% and operating margin is 13.0%, with a -4.6% net margin.
What is Charles River Laboratories's earnings per share?: Charles River Laboratories's diluted EPS over the trailing twelve months is $-3.70.
Where does Charles River Laboratories's income statement data come from?: Every line is extracted from Charles River Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.